跳至主要内容
临床试验/CTRI/2018/03/012905
CTRI/2018/03/012905已完成未知

A clinical trial to test the number of Circulating Tumor Cells (CTC) captured by the OncoDiscover Liquid Biopsy in peripheral blood samples of Head and Neck cancer patients. (CTCSEN)

Actorius Innovations and Research Pvt Ltd0 个研究点目标入组 100 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1. Males or Females.
  • 2. Age > 18 years of age.
  • 3. Written informed consent obtained.
  • Confirmed diagnosis of stage 2-4 Head and Neck, (OR) no prior history of cancer.
  • Stage 2-4 treatment naive, metastatic, secondary, and recurrent cancer patients.
  • Able to undergo blood collection prior to initiation of chemotherapy treatment, (OR) able to provide blood sample if subject is a non-cancer control subject.

排除标准

  • 1. Patients unable to understand the research protocol and/or provide informed consent.
  • 2. Patients with known immunodeficiency, or pregnancy.

研究者

发起方
Actorius Innovations and Research Pvt Ltd

相似试验